Bioprinted Kidney
End-Stage Renal Disease
Key Facts
About Vital3D Technologies
Vital3D Technologies is a private, pre-revenue biotech firm pioneering high-speed, high-precision 3D bioprinting for regenerative medicine and research. Its proprietary FemtoBrush technology integrates Two-Photon Polymerization (2PP) with Spatial Light Modulator (SLM) control, enabling the printing of complex, vascularized structures at a mesoscale. The company's long-term vision is to develop implantable, functional organs, starting with a kidney, while its near-term focus includes bioresorbable stents, advanced organoids, grafts, and vascularized tissue models for drug discovery. Leadership comprises experts in photonics, laser engineering, and business development, positioning the company at the intersection of advanced optics and biotechnology.
View full company profileOther End-Stage Renal Disease Drugs
| Drug | Company | Phase |
|---|---|---|
| Inspirex™ Kidney | Xylyx Bio | Prototype |
| UThymoKidney (Xenokidney) | United Therapeutics | Clinical (Expanded Access) |